PRAME expression extends to various other cancer types, including uveal melanoma, non-small cell lung cancer (NSCLC), kidney cancer, bladder cancer, head and neck squamous cell carcinoma (HNSCC), and esophageal carcinoma. This evidence concerns the gene PRAME and uveal melanoma.